LNAI
NASDAQ
$2.64
Lunai Bioworks Inc (LNAI)
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. The company is headquartered in Los Angeles, California.
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$13M
P/B Ratio
0.48
Free Cash Flow Yield
-37.04%
Beta (5Y)
1.20
Price Chart
Valuation
Market Cap$13M
P/S645.16
P/B0.48
Profitability
Total Revenue (TTM)$21K
Gross Profit (TTM)$21K
EBITDA-$11M
Operating Margin-6815%
EPS-$0.10
Financial Health
Free Cash Flow Yield-37.04%
Growth & Risk
EPS 5Y CAGR-64.95%
FCF 5Y CAGR-14.25%
Beta (5Y)1.20
Sharpe Ratio-0.22